Decreased In Vitro Fluoroquinolone Concentrations After Admixture With an Enteral Feeding Formulation
Authors:
- Sarah L. PietzSPSarah L. Pietz
- Frank N. KonstantinidesFKFrank N. Konstantinides
- John C. RotschaferJRJohn C. Rotschafer
- 1 January 2000
- journal article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 24 (1) , 42-48
Abstract
Background: The purpose of this study was to determine if mixing of fluoroquinolones with a common enteral feeding formulation, Ensure (Ross Products Division, Abbott Laboratories, Columbus, OH), would alter the measured in vitro quinolone concentrations over a 24‐hour period. Methods: Tablets of ciprofloxacin (500 mg), levofloxacin (500 mg), and ofloxacin (300 mg) were crushed and mixed with 240 mL of Ensure, water and calcium chloride (500 mg/L), water and magnesium chloride (200 mg/L), water and calcium chloride and magnesium chloride, and water alone. Fluoroquinolone concentrations of the mixtures were measured, via high‐performance liquid chromatography, at baseline and serially over 24 hours. Experiments were performed in duplicate, at three temperatures (5°C, 25°C, and 37°C). Results: Average decreases of 82.5% ± 1.5% for ciprofloxacin, 61.3% ± 5.2% for levofloxacin, and 45.7% ± 10.1% for ofloxacin (mean ± 95% CI) were observed in vitro for Ensure over the two experimental sets at baseline. Serial analysis revealed no further significant change in any of the quinolone concentrations over the remaining 24‐hour period. No significant decrease was noted with the quinolones when mixed in water and calcium, water and magnesium, water and calcium and magnesium, or water alone. This phenomenon appears to be unaffected by time and temperature. Conclusions: These data suggest there is an immediate and significant loss of fluoroquinolone when mixed with Ensure. An explanation for the loss of fluoroquinolone remains unclear. (Journal of Parenteral and Enteral Nutrition 24:42–48, 2000)Keywords
This publication has 33 references indexed in Scilit:
- Does Portal Nutrition Benefit Liver Protein Synthesis?Journal of Parenteral and Enteral Nutrition, 1993
- Influence of oral co-administered metallic drugs on ofloxacin pharmacokineticsJournal of Antimicrobial Chemotherapy, 1991
- Effect of staggered dose of calcium on the bioavailability of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1991
- Sucralfate significantly reduces ciprofloxacin concentrations in serumAntimicrobial Agents and Chemotherapy, 1990
- Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutritionDiagnostic Microbiology and Infectious Disease, 1990
- Ciprofloxacin Pharmacokinetics After a Standard or High‐Fat/High‐Calcium BreakfastThe Journal of Clinical Pharmacology, 1989
- Assessing and Modeling Heterosexual Spread of the Human Immunodeficiency Virus in the United StatesClinical Infectious Diseases, 1988
- CIPROFLOXACIN AND ANTACIDSThe Lancet, 1986
- The effect of food on the pharmacokinetics of ofloxacinCurrent Medical Research and Opinion, 1986
- Reduced enteral absorption of ciprofloxacin in the presence of antacidsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985